Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chembl1187319
2. Pyrazole Diamide, 29
3. Schembl12000432
4. Bdbm24650
5. Bdbm50368900
6. Db08141
7. Q27097371
8. 4-n-(2,6-difluorobenzene)-3-n-[(3s)-piperidin-3-yl]-1h-pyrazole-3,4-diamido
9. Lzd
| Molecular Weight | 349.34 g/mol |
|---|---|
| Molecular Formula | C16H17F2N5O2 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 349.13503113 g/mol |
| Monoisotopic Mass | 349.13503113 g/mol |
| Topological Polar Surface Area | 98.9 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 485 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Pyrazole Diamide, 29 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pyrazole Diamide, 29, including repackagers and relabelers. The FDA regulates Pyrazole Diamide, 29 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pyrazole Diamide, 29 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pyrazole Diamide, 29 supplier is an individual or a company that provides Pyrazole Diamide, 29 active pharmaceutical ingredient (API) or Pyrazole Diamide, 29 finished formulations upon request. The Pyrazole Diamide, 29 suppliers may include Pyrazole Diamide, 29 API manufacturers, exporters, distributors and traders.
click here to find a list of Pyrazole Diamide, 29 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pyrazole Diamide, 29 DMF (Drug Master File) is a document detailing the whole manufacturing process of Pyrazole Diamide, 29 active pharmaceutical ingredient (API) in detail. Different forms of Pyrazole Diamide, 29 DMFs exist exist since differing nations have different regulations, such as Pyrazole Diamide, 29 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pyrazole Diamide, 29 DMF submitted to regulatory agencies in the US is known as a USDMF. Pyrazole Diamide, 29 USDMF includes data on Pyrazole Diamide, 29's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pyrazole Diamide, 29 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pyrazole Diamide, 29 suppliers with USDMF on PharmaCompass.
Pyrazole Diamide, 29 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pyrazole Diamide, 29 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pyrazole Diamide, 29 GMP manufacturer or Pyrazole Diamide, 29 GMP API supplier for your needs.
A Pyrazole Diamide, 29 CoA (Certificate of Analysis) is a formal document that attests to Pyrazole Diamide, 29's compliance with Pyrazole Diamide, 29 specifications and serves as a tool for batch-level quality control.
Pyrazole Diamide, 29 CoA mostly includes findings from lab analyses of a specific batch. For each Pyrazole Diamide, 29 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pyrazole Diamide, 29 may be tested according to a variety of international standards, such as European Pharmacopoeia (Pyrazole Diamide, 29 EP), Pyrazole Diamide, 29 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pyrazole Diamide, 29 USP).
LOOKING FOR A SUPPLIER?
